New Delhi, Feb. 17 -- Shares of GlaxoSmithKline Pharmaceuticals hit the 20 per cent upper circuit at Rs.2,421.30 per share on the BSE on Monday, February 17, following an impressive financial performance in the quarter ended December 2024 (Q3FY25). The pharmaceutical company reported a five-fold surge in net profit, driven by strong operational performance and the absence of one-time charges that impacted the previous year's earnings.

GlaxoSmithKline Pharmaceuticals posted a 400 per cent jump in consolidated net profit to Rs.230 crore, compared to Rs.46 crore in the corresponding quarter last year. Meanwhile, the company's revenue grew 18 per cent year-on-year (YoY) to Rs.949.42 crore from Rs.805.26 crore in Q3FY24.

The sharp rise in ne...